iBio Appoints Dr. Martin Brenner as CEO, Felipe Duran as CFO to Oversee Company's Next Stage of Growth tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
LSHTM maintains a governance framework comprising a range of principles, policies, procedures and guidelines that regulate our research. This has been developed in accordance with national guidance. Research governance The Research Governance Committee oversees research governance matters across LSHTM, including the policy on Good Research Practice.
Share this article
Share this article
SHANGHAI, April 8, 2021 /PRNewswire/ Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel target discovery and development of novel therapeutics, today announced the appointment of Dr. Eric Rowinsky, President and Executive Chairman of the Board of Rgenix, Inc., and Dr. Manuel Hidalgo, Chief of Hematology and Medical Oncology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, to its Scientific Advisory Board. Drs. Rowinsky and Hidalgo will bring their strong expertise in translational and clinical development to support Genechem s mission to bring its innovative pipeline to global markets through novel target discovery, early development in China, and global partnership.
Shanghai Genchem Co., Ltd. (Genechem) Announces Global Collaboration on Bispecific Antibodies
SHANGHAI, April 6, 2021 /PRNewswire/ Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel therapeutics, today announced the execution of a global collaboration with I-Mab (Nasdaq: IMAB), a Nasdaq-listed global biopharmaceutical company, to develop and commercialize multiple bi-specific antibodies (BsAb) based on monoclonal antibody developed by Genechem and antibodies selected by I-MAB. This collaboration is the first of many that will leverage Genechem s Good Research Practice (GRP) and CHAMP antibody discovery platform, strong bioinformatic database, as well as strong development expertise of synergistic partners, to deliver globally competitive assets based on innovative targets. We are excited to collaborate with I-Mab, a global leader in Oncology and antibody development, to bring more products to address clin
Shanghai Genchem Co., Ltd. (Genechem) Announces Global Collaboration on Bispecific Antibodies prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.